Novartis AG (FRA:NOTA)

Germany flag Germany · Delayed Price · Currency is EUR
108.00
+3.00 (2.86%)
At close: Sep 30, 2025
2.86%
Market Cap207.17B
Revenue (ttm)46.99B
Net Income (ttm)11.63B
Shares Outn/a
EPS (ttm)5.83
PE Ratio17.82
Forward PE14.71
Dividend3.10 (2.99%)
Ex-Dividend DateMar 12, 2025
Volumen/a
Average Volume127
Open103.50
Previous Close105.00
Day's Range103.50 - 108.00
52-Week Range88.20 - 110.50
Betan/a
RSI51.87
Earnings DateOct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 75,883
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol NOTA
Full Company Profile

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.